FGL (Fibroblast Growth-Like) vs Thymosin Alpha-1

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

FGL (Fibroblast Growth-Like) is primarily a healing & recovery peptide, while Thymosin Alpha-1 is used for immune support.

This page compares FGL (Fibroblast Growth-Like) and Thymosin Alpha-1 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

FGL (Fibroblast Growth-Like)Thymosin Alpha-1
CategoryHealing & RecoveryImmune Support
Regulatory status (US)Research use onlyResearch use only
Typical dosage1 mg1.6-3.2 mg
Frequencydailytwice weekly
Reported benefitsNeuroprotection, neural repair, cognitive supportEnhanced immune function, antiviral properties, vaccine response improvement, cancer therapy support
Reported side effectsResearch phase, limited dataWell-tolerated, rare injection site reactions

Key differences

Primary use. FGL (Fibroblast Growth-Like) is categorised under Healing & Recovery, while Thymosin Alpha-1 falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. FGL (Fibroblast Growth-Like): not FDA-approved; treated as a research compound. Thymosin Alpha-1: not FDA-approved; treated as a research compound.

Dosing. FGL (Fibroblast Growth-Like) is typically dosed at 1 mg (daily). Thymosin Alpha-1 is typically dosed at 1.6-3.2 mg (twice weekly).

Can you stack them?

Some protocols combine peptides, but stacking FGL (Fibroblast Growth-Like) and Thymosin Alpha-1 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between FGL (Fibroblast Growth-Like) and Thymosin Alpha-1?
FGL (Fibroblast Growth-Like) is primarily a healing & recovery peptide, while Thymosin Alpha-1 is used for immune support. FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound, whereas Thymosin Alpha-1 is not FDA-approved; generally classified as a research compound.
What is FGL (Fibroblast Growth-Like) used for?
Neural repair peptide.
What is Thymosin Alpha-1 used for?
Potent immune modulator.
Can you take FGL (Fibroblast Growth-Like) and Thymosin Alpha-1 together?
Some users combine peptides within a single protocol, but stacking FGL (Fibroblast Growth-Like) and Thymosin Alpha-1 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is FGL (Fibroblast Growth-Like) or Thymosin Alpha-1 FDA-approved?
FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound. Thymosin Alpha-1 is not FDA-approved; generally classified as a research compound.

Read the full articles

More Healing & Recovery comparisons

← All peptide comparisons